Histogen Inc. Profile Avatar - Palmy Investing

Histogen Inc.

Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clini…

Biotechnology
US, San Diego [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Histogen Inc. has no acquisition track records yet.

M&A Deals · History

Histogen Inc. has no acquisition track records yet.

End of HSTO's Analysis
CIK: 1383701 CUSIP: 43358Y103 ISIN: US43358Y2028 LEI: - UEI: -
Secondary Listings
HSTO has no secondary listings inside our databases.